Search Results - "Takabatake D"

5145 POSTER Evaluation of Clinical Utility of Sentinel Lymph Node (SLN) Examination by One-step Nucleic Acid Amplification (OSNA) Assay in Breast Cancer

Authors: Takabatake, D. Noguchi, S. Akiyama, F. et al.

Source: European Journal of Cancer. Sep2011 Supplement 1, Vol. 47, pS373-S373. 1p.

Clinical significance of multidetector-row computed tomography in breast surgery.

Authors: Doihara H Fujita T Takabatake D et al.

Source: Breast Journal. Sep2006 Supplement, Vol. 12, pS204-9. 1p.

URL: 22165213

PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer.

Authors: Fujita, T. Doihara, H. Kawasaki, K. et al.

Source: British Journal of Cancer. 1/30/2006, Vol. 94 Issue 2, p247-252. 6p. 4 Diagrams, 5 Graphs.

359P Overall survival of palbociclib (PAL) + endocrine therapy (ET) in Japanese patients with hormone receptor-positive (HR+)/ human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in the 1st line (1L) or 2nd line (2L) setting: A multicenter observational study

Authors: Nakayama, T. Nagai, S.E. Hattori, M. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS368-S368. 1p.

80 (PB-080) Poster - The impact of the gut microbiota on neoadjuvant chemotherapy for breast cancer: the Setouchi Breast Project-14.

Authors: Kajiwara, Y. Nakamoto, S. Hida, A. et al.

Source: European Journal of Cancer. Mar2024:Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p.

61 (PB-061) Poster - Effects of exercise and education programs on cancer-related fatigue after initial treatment for breast cancer: Secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10.

Authors: Zhu, Y. Iwamoto, T. Kawada, K. et al.

Source: European Journal of Cancer. Mar2024:Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p.

Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: Results of a multicenter study in Japan.

Authors: Tamaki Y Sato N Homma K et al.

Source: Cancer (0008543X). Jul2012, Vol. 118 Issue 14, p3477-3483. 7p.

Clinical significance of multidetector-row computed tomography in breast surgery

Authors: Doihara, H. Fujita, T. Takabatake, D. et al.

Source: Clinical Imaging. Mar2007, Vol. 31 Issue 2, p145-145. 1p.

176P The effectiveness of long-term physical activity after exercise and educational programs on breast cancer-related lymphoedema: Secondary analyses from a randomized controlled trial: The Setouchi Breast Project 10.

Authors: Nakamoto, S. Taira, N. Kawada, K. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS618-S618. 1p.

531 Image-guided Radiofrequency Ablation in Patients with Primary Breast Carcinoma-a Multicenter Study of 40 Patients-

Authors: Kinoshita, T. Tsuda, H. Hojo, T. et al.

Source: European Journal of Cancer. Mar2012 Supplement, Vol. 48 Issue s2, pS201-S201. 1p.

291 Breast Cancer with PIK3Ca Mutations Associated with a Favorable Prognosis in Patients Treated with Tamoxifen Alone

Authors: Hara, F. Kiyoto, S. Takahashi, M. et al.

Source: European Journal of Cancer. Mar2012 Supplement, Vol. 48 Issue s2, pS127-S127. 1p.

Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness).

Authors: Taji T Uemura Y Kimura Y et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2026 Jul; Vol. 33 (4), pp. 919-927. Date of Electronic Publication: 2026 May 23.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

Clinical benefit of palbociclib retreatment after abemaciclib exposure in hormone receptor positive, HER2 negative metastatic breast cancer.

Authors: Yu M Yamashita M Takada M et al.

Source: Scientific reports [Sci Rep] 2026 Jun 20. Date of Electronic Publication: 2026 Jun 20.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Real-world data for a CDK4/6 inhibitor, palbociclib, as 1st- or 2nd-line therapy in HR+/HER2- metastatic breast cancer: a multicenter prospective cohort study.

Authors: Ishikawa T Uemura Y Seki H et al.

Source: Breast cancer research : BCR [Breast Cancer Res] 2026 May 29. Date of Electronic Publication: 2026 May 29.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial.

Authors: Kikawa Y Uemura Y Taira T et al.

Source: JAMA network open [JAMA Netw Open] 2025 Aug 01; Vol. 8 (8), pp. e2527403. Date of Electronic Publication: 2025 Aug 01.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Validation of the Symptom Illustration Scale within an electronic Patient-Reported Outcomes Monitoring environment for metastatic breast cancer patients undergoing chemotherapy.

Authors: Jo A Iwamoto T Suzuki Y et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2025 Jul; Vol. 32 (4), pp. 783-791. Date of Electronic Publication: 2025 Apr 10.

Publication Type: Journal Article; Validation Study

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study).

Authors: Nagai SE Hattori M Yoshinami T et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2025 Jul; Vol. 32 (4), pp. 705-715. Date of Electronic Publication: 2025 Apr 05.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study).

Authors: Nagai SE Hattori M Yoshinami T et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2026 Mar; Vol. 33 (2), pp. 559-568.

Publication Type: Published Erratum

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE; In Process

Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group.

Authors: Masuda H Nagai SE Hattori M et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2026 Mar; Vol. 33 (2), pp. 333-345. Date of Electronic Publication: 2026 Feb 11.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14.

Authors: Nakamoto S Kajiwara Y Taniguchi K et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Nov; Vol. 208 (1), pp. 67-77. Date of Electronic Publication: 2024 Jun 18.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE